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Quality of life (QOL) has become an important treatment goal in chronic diseases, including 
cystic fibrosis, as longevity has increased and medical research has progressed (Abbott & 
Gee, 2003; Gee, Abbott, Conway, Etherington & Webb, 2003). However, using QOL as a 
concept for children has only recently been recognized as useful. Consequently, QOL of 
children aged 6 to 12 years is underinvestigated (Wallander & Schmitt, 2001). Specific 
measures are generally used to assess QOL of patients with CF. Nevertheless, these measures 
do not allow comparison between CF and healthy children. To overcome this drawback, we 
promote the development of an assessment tool of QOL based on a modular approach. This 
study examined the generic and CF-specific QOL in CF children using a tool based on a 
modular clinical approach. 
Sample consisted of 12 CF 
children and 12 healthy 
children aged 8 to 12 years, 
matched by age and sex.  
Participants 
Measure 
The Quality of Life Systemic Inventory 
for Children (QLSI-C; Dupuis, Perrault, 
Lambany, Kennedy & David, 1989) 
assess both generic (20 items) and CF-
specific (6 items) QOL. CF-specific 
module is empirically created from CFQ-
R and discussion with medical staff. 
QLSI-C is a dynamic tool, using a VAS.  
QLSI-C considers QOL (gap score) like the difference between the present situation 
(state score) and the expectations (goal score). This difference is weighted by the 
importance (rank score) that children assign for each life domains.  
Generic items (20 items)        CF-specific items (6 items) 
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These findings bring out the importance to have a flexible tool which allow to analyze  both 
QOL for each life domains and overall QOL 
This new tool suggests ways of intervention depending on child specific difficulties. His 
clinical originality is strengthened by the consideration of individual life plan taking into 
account the particular situation of children with CF. 
Generic module VS CF-specific module 
For the gap score: a low mean suggest a better QOL 
CF childrenVS healthy children 
• Global scores in CF-specific module is correlated with global 
score in generic module for CF children (r=0.66 to 0.96).  
• Assessment of QOL is the same for both generic (M=3.76) and 
CF-specific (M=3.76) module (p=0.53).  
There is no difference between CF and healthy children.  
Nevertheless, p for the QOL (Gap score) approached significance. 
  
Results by items show a significant difference between the two groups for: 
• “autonomy” (CF children: 5,96(8,92); healthy children : 0,60(0,83); F=4.30; p=0.05)  
•“frustration tolerance” (CF children: 5,40(5,90); healthy children : 1,61(1,61); F=4.60; 
p=0.04) 
Items with best QOL VS worse QOL 
Children with CF assess their health-related QOL (CF-specific module) in the same way 
that their overall QOL (generic module) and they have a good overall QOL as healthy 
children. However, we note that, clinically, children with CF have a worse QOL than the 
control group. This clinical difference can be explained by the fact that CF children have 
a lower present situation and higher expectations than healthy children. In this medical 
condition, we could think that children with CF have lower goal than healthy children. 
Results of comparison by items emphasize significant differences between CF children 
and healthy children for the “autonomy” and the “frustration tolerance”. Analysis of the 
best and worse items among CF and healthy children has highlighted that a poor QOL is 
observed for "autonomy" in CF children in contrast to healthy children who have a good 
QOL in this life domain. Finally, the best QOL in CF children were based on social 









1. Sleep 11. Relation with my siblings 21. Emotional state 
2. Eating  12. relation with my friends 22. Treatment constraints 
3. Physical pain 13. How my friends describe me 23. Physical functioning 
4. Health 14. School 24. Respiratory symptoms 
5. Clothes 15. School performance 25. Digestive and weight symptoms 
6. Body image 16. Sport 26. Relation with medical staff 
7. Bedroom 17. Leisure   
8. Relation with grandparents 18. Autonomy   
9. Relation with my mother 19. Obedience to authority   
10. Relation with my fathers 20. Frustration tolerance   
  Children with CF Healthy children 






Relation with mother -0.21 (1.21) Sport  0.33 (0.59) 
Relation with father  0.23 (0.62) How my friends describe me  0.35 (1.59) 
Relation with grandparents  0.38 (0.96) Clothes  0.49 (0.68) 
Leisure  0.80 (1.35) Autonomy  0.60 (0.83) 






Siblings  11.65 (27.17) Siblings   6.14 (12.99) 
Health  7.70 (10.30) Health  3.32 (4.17) 
Eating 7.63 (14.20) Physical pain 2.93 (2.88) 
Frustration tolerance  5.40 (5.90) Bedroom  2.79 (4.33) 
Autonomy  5.96 (8.92) Sleep  2.48 (2.03) 
  
Children with CF 
N = 12 
Healthy children 
N = 12 
  
  
  M(SD) M(SD) dl F p 
STATE 18,77 (2,78) 15,37 (3,71) 22 0,54 0,47 
GOAL 5,98 (1,41) 8,70 (3,18) 22 0,61 0,44 
GAP 3,76 (1,07) 1,64 (0,30) 22 3,63 0,07** 
RANK 1,69 (0,05) 1,66 (0,03) 22 0,19 0,67 
CONCLUSION    
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